1-Discuss clinical features and laboratory markers can be used to classify pediatric patients with febrile neutropenia (FN ) as being at low or high risk for poor outcomes?
2-Discuss the research question; Does depth and duration of neutropenia at presentation predict outcomes? Comparison between IDSA guidelines and my research study results
3-Discuss the research question; Prolonged vs recurrent FN; Should management differ ?
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation